Extra-Gastrointestinal Stromal Tumor (EGIST) in the Pelvis Mimicking Retroperitoneal Sarcoma
Open Access
- 26 September 2022
- journal article
- case report
- Published by Georg Thieme Verlag KG in The Surgery Journal
- Vol. 08 (03) , e266-e269
Abstract
Extra-gastrointestinal stromal tumors (EGISTs) are rare mesenchymal tumors accounting for less than 1% of total gastrointestinal tumors. They tend to be aggressive and have a poor prognosis. Unfortunately, there is a lack of data or controversial data due to its scarcity. Therefore, we report a case of pelvic EGIST misdiagnosed as retroperitoneal sarcoma. We opted for surgical management followed by adjuvant oral chemotherapy with imatinib. * These authors contributed equally to this work. Received: 02 January 2022 Accepted: 07 September 2022 Article published online: 26 September 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAKeywords
This publication has 4 references indexed in Scilit:
- Clinical Features of Extragastrointestinal Stromal Tumor Compared with Gastrointestinal Stromal Tumor: A Retrospective, Multicenter, Real-World StudyJournal of Oncology, 2021
- Perirectal Extragastrointestinal Stromal Tumor: An Unusual PresentationCureus, 2021
- Curative intent treatment of late presented extragastrointestinal stromal tumor: two identical case reports with literature reviewJournal of Surgical Case Reports, 2021
- Primary extra gastrointestinal stromal tumors of the abdomenNorthern Clinics of Istanbul, 2021